Abstract:BackgroundCyclic peptide-based drug discovery is attracting increasing interest owing to its potential to avoid target protein depletion. In drug discovery, it is important to maintain the biostability of a drug within the proper range. Plasma protein binding (PPB) is the most important index of biostability, and developing a computational method to predict PPB of drug candidate compounds contributes to the acceleration of drug discovery research. PPB prediction of small molecule drug compounds using machine learning has been conducted thus far; however, no study has investigated cyclic peptides because experimental information of cyclic peptides is scarce.ResultsFirst, we adopted sparse modeling and small molecule information to construct a PPB prediction model for cyclic peptides. As cyclic peptide data are limited, applying multidimensional nonlinear models involves concerns regarding overfitting. However, models constructed by sparse modeling can avoid overfitting, offering high generalization performance and interpretability. More than 1000 PPB data of small molecules are available, and we used them to construct a prediction models with two enumeration methods: enumerating lasso solutions (ELS) and forward beam search (FBS). The accuracies of the prediction models constructed by ELS and FBS were equal to or better than those of conventional non-linear models (MAE = 0.167–0.174) on cross-validation of a small molecule compound dataset. Moreover, we showed that the prediction accuracies for cyclic peptides were close to those for small molecule compounds (MAE = 0.194–0.288). Such high accuracy could not be obtained by a simple method of learning from cyclic peptide data directly by lasso regression (MAE = 0.286–0.671) or ridge regression (MAE = 0.244–0.354).ConclusionIn this study, we proposed a machine learning techniques that uses low-dimensional sparse modeling to predict the PPB value of cyclic peptides computationally. The low-dimensional sparse model not only exhibits excellent generalization performance but also improves interpretation of the prediction model. This can provide common an noteworthy knowledge for future cyclic peptide drug discovery studies.

Multi_CycGT: A Deep Learning-Based Multimodal Model for Predicting the Membrane Permeability of Cyclic Peptides

CycPeptMP: enhancing membrane permeability prediction of cyclic peptides with multi-level molecular features and data augmentation

MuCoCP: a priori chemical knowledge-based multimodal contrastive learning pre-trained neural network for the prediction of cyclic peptide membrane penetration ability

Large-Scale Membrane Permeability Prediction of Cyclic Peptides Crossing a Lipid Bilayer Based on Enhanced Sampling Molecular Dynamics Simulations

NCPepFold: Accurate Prediction of Non-canonical Cyclic Peptide Structures via Cyclization Optimization with Multigranular Representation

Lipid Composition Is Critical for Accurate Membrane Permeability Prediction of Cyclic Peptides by Molecular Dynamics Simulations

Membrane Permeability in a Large Macrocyclic Peptide Driven by a Saddle-Shaped Conformation

Predicting Peptide Permeability Across Diverse Barriers: A Systematic Investigation

Training Neural Network Models Using Molecular Dynamics Simulation Results to Efficiently Predict Cyclic Hexapeptide Structural Ensembles

MMDB: Multimodal Dual-Branch Model for Multi-Functional Bioactive Peptide Prediction

CREMP: Conformer-rotamer ensembles of macrocyclic peptides for machine learning

Cyclic peptide structure prediction and design using AlphaFold

Multi-Peptide: Multimodality Leveraged Language-Graph Learning of Peptide Properties

Peptide-specific chemical language model successfully predicts membrane diffusion of cyclic peptides

Peptide-aware chemical language model successfully predicts membrane diffusion of cyclic peptides

Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides

Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations

Multi-CGAN: Deep Generative Model-Based Multiproperty Antimicrobial Peptide Design

MMDTA: A Multimodal Deep Model for Drug-Target Affinity with a Hybrid Fusion Strategy

Gaussian accelerated molecular dynamics simulations facilitate prediction of the permeability of cyclic peptides

Computational prediction of plasma protein binding of cyclic peptides from small molecule experimental data using sparse modeling techniques